Ying Yue

691 citations
21 papers · 233 indexed · h-index 10
Topics
Cancer-related molecular mechanisms research (4 papers)CRISPR and Genetic Engineering (3 papers)Virus-based gene therapy research (2 papers)
Partner nations
ChinaUnited StatesKenya

In The Last Decade

Ying Yue

19 papers receiving 230 citations

Peers

Ying Yue
Comparison fields: 5 of 62
  • Molecular Biology 98
  • Cancer Research 43
  • Psychiatry and Mental health 37
  • Oncology 34
  • Epidemiology 34
Replace Amy Gerrish with:
Amy Gerrish United Kingdom
Bérengère Génin France
San‐Duk Yang South Korea
Tania Di Raimo Italy
Shen Li China
Litian Ma China
Alessandra Gasparini Italy
Yulin Zhao United States
Faisal Hayat Nazir Sweden
Ying Yue relative to Amy Gerrish United Kingdom Amy Gerrish's profile →
Citations per field
00.5×3.1×
Amy Gerrish · 1×
Citations per year

Countries citing papers authored by Ying Yue

Since Specialization
Citations

This map shows the geographic impact of Ying Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Yue more than expected).

Fields of papers citing papers by Ying Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Yue. The network helps show where Ying Yue may publish in the future.

Co-authorship network of co-authors of Ying Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Yue. A scholar is included among the top collaborators of Ying Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Yue. Ying Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 10
4 7
5 5
6 10
7 4
8 24
9 9
10 6
11 11
12 40
13 22
14 44
15 13
16 3
17
Expression, purification and biological activity of a cell-permeable Cre recombinase
1
18 2
19 18
20
[DNase I sensitivity of nucleus and chromatin in six different tissues of old rates].
0

About Ying Yue

Ying Yue is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 21 papers that have together received 233 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), CRISPR and Genetic Engineering (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Biological Psychiatry (8 citations), Cancer Research (43 citations) and Psychiatry and Mental health (37 citations). Ying Yue has collaborated with scholars based in China, United States and Kenya. Frequent co-authors include Yifeng Xu, Na Zhou, Chunbo Li, Hui Su, Shan Zong, Xiaoxia Liu, Jijun Wang, Li Kong, Ling Tan and Yunkai Zhai. Their work appears in journals such as PLoS ONE, Biochemical Journal and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026